ACCURAY INC
ARAY · XNASCIK 1138723fmd_1BVDS7ZVBHX3QNB0GM07B1F62JManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jul 01, 2009 to Sep 30, 2026, 66 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 383 | 405 | 419 | 383 | 396 | 430 | 448 | 447 | 459 | 402 |
| Cost of revenue | 242 | 243 | 256 | 233 | 237 | 270 | 294 | 304 | 312 | 290 |
| Gross profit | 141 | 162 | 163 | 150 | 160 | 160 | 154 | 143 | 147 | 111 |
| Realized investment gains (losses) | – | – | – | 13 | 0 | 0 | – | – | – | – |
| Provision for credit losses | – | – | – | – | – | – | – | (0) | (0) | 1 |
| Research and development | 50 | 57 | 56 | 50 | 53 | 58 | 57 | 50 | 48 | 38 |
| Selling, general and administrative | 101 | 108 | 106 | 87 | 85 | 94 | 94 | 93 | 91 | 84 |
| Total operating expenses | 151 | 165 | 162 | 137 | 137 | 152 | 152 | 142 | 139 | 138 |
| Operating income | (10) | (4) | 1 | 13 | 22 | 8 | 2 | 1 | 8 | (26) |
| Interest expense | 17 | 15 | 15 | 18 | 17 | 8 | 11 | 12 | 13 | 33 |
| Interest and investment income | – | – | – | – | – | – | – | 1 | 1 | 1 |
| Other non-operating income (expense) | (19) | (19) | (15) | (7) | (28) | (2) | (1) | (3) | 1 | 5 |
| Income before taxes | (29) | (23) | (14) | 6 | (5) | (2) | (7) | (12) | 1 | (47) |
| Income tax expense | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 4 | 3 | 2 |
| Net income from continuing operations | (30) | (24) | (16) | 4 | (6) | (5) | (9) | (16) | (2) | (49) |
| Net income | (30) | (24) | (16) | 4 | (6) | (5) | (9) | (16) | (2) | (49) |
| Net income to common shareholders | (30) | – | – | – | – | – | – | (16) | (2) | (49) |